跳转至内容
Merck
CN
  • Effects of tanshinones from Salvia miltiorrhiza on CYP2C19 activity in human liver microsomes: enzyme kinetic and molecular docking studies.

Effects of tanshinones from Salvia miltiorrhiza on CYP2C19 activity in human liver microsomes: enzyme kinetic and molecular docking studies.

Chemico-biological interactions (2015-02-18)
Tao Hu, Xuelin Zhou, Lin Wang, Penelope M Y Or, John H K Yeung, Yiu Wa Kwan, Chi Hin Cho
摘要

This study aimed to investigate the effects of five tanshinones, the lipophilic components from Danshen (Salvia miltiorrhiza), on CYP2C19 activity in pooled human liver microsomes (HLMs). The effects of tanshinones on CYP2C19 activity were compared by enzyme inhibition study using omeprazole 5-hydroxylation in pooled HLMs. The inhibition constant (Ki) values and inhibition modes of effective tanshinones were evaluated by enzyme kinetic study. Molecular docking analysis was used to simulate the binding conformations of tanshinones to the active cavity of human CYP2C19. Dihydrotanshinone and miltirone showed potent inhibitory effects on CYP2C19 activity in a concentration-dependent manner. Tanshinone I showed weaker inhibitory effect, whereas tanshinone IIA and cryptotanshinone had no inhibitory effect. Further enzyme kinetic study showed that the inhibition by dihydrotanshinone and miltirone was a mixed type. The effects of tanshinones were also confirmed by a molecular docking study. Besides, the ethanol extract of Danshen also showed a mixed type of inhibition, whereas the water extract had no inhibitory effect. The current findings demonstrate the inhibition of CYP2C19 activity by the ethanol extract of Danshen and its components tanshinones, implicating the potential herb-drug interactions between Danshen and therapeutic agents metabolized by CYP2C19 in clinical practice.

材料
Product Number
品牌
产品描述

Supelco
奥美拉唑, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
奥美拉唑, solid
USP
奥美拉唑, United States Pharmacopeia (USP) Reference Standard
Supelco
5-Hydroxyomeprazole, analytical standard
Supelco
奥美拉唑, analytical standard
奥美拉唑, European Pharmacopoeia (EP) Reference Standard
奥美拉唑, European Pharmacopoeia (EP) Reference Standard